FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+6.06%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$41.9B
AUM Growth
-$427M
(-1%)
Cap. Flow
+$69.7M
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
26.21%
Holding
592
New
84
Increased
188
Reduced
187
Closed
80
Top Buys
| 1 |
Tesla
TSLA
|
$488M |
| 2 |
Sea Limited
SE
|
$326M |
| 3 |
Advanced Micro Devices
AMD
|
$290M |
| 4 |
InMode
INMD
|
$191M |
| 5 |
Apple
AAPL
|
$182M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$293M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$267M |
| 3 |
Pinterest
PINS
|
$187M |
| 4 |
NXP Semiconductors
NXPI
|
$168M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$147M |
Sector Composition
| 1 | Technology | 34.68% |
| 2 | Healthcare | 20.73% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Financials | 8.79% |
| 5 | Industrials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Personalis
PSNL
$465M
| $2.91M | 0.01% |
151,469
-129,400
| -46% | -$2.49M |
|
327
SOPHiA GENETICS
SOPH
$219M
| $2.84M | 0.01% |
+162,082
| New | +$2.84M |
|
328
Cisco
CSCO
$264B
| $2.7M | 0.01% |
49,526
-9,333
| -16% | -$508K |
|
329
dLocal
DLO
$3.94B
| $2.69M | 0.01% |
+49,223
| New | +$2.69M |
|
|
FLXN
330
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.68M | 0.01% |
+438,619
| New | +$2.68M |
|
|
TPTX
331
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.65M | 0.01% |
39,881
-22,305
| -36% | -$1.48M |
|
332
Cabaletta Bio
CABA
$155M
| $2.61M | 0.01% |
+214,721
| New | +$2.61M |
|
333
Arrowhead Research
ARWR
$4.02B
| $2.61M | 0.01% |
41,803
+15,249
| +57% | +$952K |
|
334
CVS Health
CVS
$93.6B
| $2.6M | 0.01% |
30,602
| – | – |
|
|
ONEM
335
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $2.59M | 0.01% |
127,695
-26,778
| -17% | -$542K |
|
336
Olema Pharmaceuticals
OLMA
$570M
| $2.56M | 0.01% |
+92,785
| New | +$2.56M |
|
337
Coca-Cola
KO
$292B
| $2.51M | 0.01% |
47,892
| – | – |
|
338
Chevron
CVX
$310B
| $2.45M | 0.01% |
24,180
+681
| +3% | +$69.1K |
|
339
Rapid Micro Biosystems
RPID
$120M
| $2.43M | 0.01% |
+131,505
| New | +$2.43M |
|
340
Cytek Biosciences
CTKB
$511M
| $2.42M | 0.01% |
+112,980
| New | +$2.42M |
|
341
Avidity Biosciences
RNA
$6.48B
| $2.34M | 0.01% |
+94,805
| New | +$2.34M |
|
|
CNVY
342
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $2.31M | 0.01% |
275,088
+4,138
| +2% | +$34.8K |
|
343
Privia Health
PRVA
$2.86B
| $2.3M | 0.01% |
97,628
+1,543
| +2% | +$36.4K |
|
344
NextEra Energy, Inc.
NEE
$146B
| $2.11M | 0.01% |
26,910
+835
| +3% | +$65.6K |
|
345
Autodesk
ADSK
$69.5B
| $2.1M | 0.01% |
7,379
-165,721
| -96% | -$47.3M |
|
346
Merck
MRK
$212B
| $2.05M | ﹤0.01% |
27,241
| – | – |
|
347
Larimar Therapeutics
LRMR
$337M
| $2.03M | ﹤0.01% |
+175,870
| New | +$2.03M |
|
348
Bristol-Myers Squibb
BMY
$96B
| $1.89M | ﹤0.01% |
31,929
-252
| -0.8% | -$14.9K |
|
349
Pfizer
PFE
$141B
| $1.87M | ﹤0.01% |
43,512
+1,695
| +4% | +$72.9K |
|
350
Sysco
SYY
$39.4B
| $1.87M | ﹤0.01% |
23,797
-985,016
| -98% | -$77.3M |
|